Pebble Biotechnology Laboratories Ltd

General information

Name:

Pebble Biotechnology Laboratories Limited

Office Address:

122, Beech Court Hollin Lane Styal SK9 4LD Wilmslow

Number: 11278041

Incorporation date: 2018-03-27

End of financial year: 31 March

Category: Private Limited Company

Status: Active

Description

Data updated on:

Pebble Biotechnology Laboratories Ltd may be contacted at 122, Beech Court Hollin Lane, Styal in Wilmslow. The postal code is SK9 4LD. Pebble Biotechnology Laboratories has been present on the British market since it was established on 2018-03-27. The registered no. is 11278041. This firm changed its name two times. Up till 2022 it has been working on providing the services it's been known for under the name of Perfusion Biotechnology but now it is registered under the business name Pebble Biotechnology Laboratories Ltd. This enterprise's Standard Industrial Classification Code is 72110 and has the NACE code: Research and experimental development on biotechnology. 2022-03-31 is the last time the company accounts were reported.

That business owes its achievements and constant improvement to four directors, namely Anthony F., Douglas S., Mark C. and James F., who have been managing the company since 2022-11-01.

James F. is the individual who controls this firm, owns over 1/2 to 3/4 of company shares and has over 1/2 to 3/4 of voting rights.

  • Previous company's names
  • Pebble Biotechnology Laboratories Ltd 2022-11-03
  • Perfusion Biotechnology Ltd 2021-06-21
  • Perfusion Research Ltd 2018-03-27

Financial data based on annual reports

Company staff

Anthony F.

Role: Director

Appointed: 01 November 2022

Latest update: 24 February 2024

Douglas S.

Role: Director

Appointed: 22 July 2021

Latest update: 24 February 2024

Mark C.

Role: Director

Appointed: 22 July 2021

Latest update: 24 February 2024

James F.

Role: Director

Appointed: 27 March 2018

Latest update: 24 February 2024

People with significant control

James F.
Notified on 27 March 2018
Nature of control:
over 1/2 to 3/4 of shares
over 1/2 to 3/4 of voting rights
right to manage directors

Accounts Documents

Account next due date 31 December 2023
Account last made up date 31 March 2022
Confirmation statement next due date 09 April 2024
Confirmation statement last made up date 26 March 2023
Annual Accounts
Start Date For Period Covered By Report 2018-03-27
End Date For Period Covered By Report 2019-03-31
Annual Accounts
Start Date For Period Covered By Report 1 April 2020
End Date For Period Covered By Report 31 March 2021
Annual Accounts
Start Date For Period Covered By Report 2021-04-01
End Date For Period Covered By Report 2022-03-31
Annual Accounts
Start Date For Period Covered By Report 2022-04-01
End Date For Period Covered By Report 2023-03-31
Annual Accounts
End Date For Period Covered By Report 2020-03-31

Company filings

Filing category

Hide filing type
Accounts Address Capital Change of name Confirmation statement Incorporation Officers Persons with significant control Resolution
Free Download
Total exemption full accounts data made up to 31st March 2023 (AA)
filed on: 21st, December 2023
accounts
Free Download Download filing (10 pages)

Search other companies

Services (by SIC Code)

  • 72110 : Research and experimental development on biotechnology
6
Company Age

Closest Companies - by postcode